International Stem Cell Corp. operates as a research and development company for the therapeutic market. It focuses on advancing potential clinical applications of human parthenogenetic stem cells for the treatment of various diseases of the central nervous system and liver diseases. The firm operates through three segments: Therapeutic Market, Biomedical Market and Anti-Aging Market. The Biomedical Market segment markets and sells primary human cell research products with two product categories, cells and media. The Anti-Aging market segment markets and sells a line of skincare products sold through two sales channels: ecommerce and professional. The ecommerce channel sells direct to customers through online orders, while professional sales are to spas, salons and other skincare providers. The Therapeutic Market segment focuses on the research and development of human parthenogenetic stem cells for the treatment of diseases of the central nervous system, liver diseases and is currently conducting clinical trials for the treatment of Parkinson's disease. The company was founded by William B. Adams, Kenneth C. Aldrich and Gregory S. Keller in June 2005 and is headquartered in San Diego, CA.
Sector:
Health Technology
Industry:
Medical Specialties
Employees:
32
Frequently Asked Questions
What is Market Cap of International Stem Cell Corporation?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. International Stem Cell Corporation market cap is $1.15M.
What is the 52-week high for International Stem Cell Corporation?
52 week high is the highest price of a stock in the past 52 weeks, or one year. International Stem Cell Corporation 52 week high is $0.2726 as of October 11, 2025.
What is the 52-week low for International Stem Cell Corporation?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. International Stem Cell Corporation 52 week low is $0.056 as of October 11, 2025.
What is International Stem Cell Corporation stock price today?
International Stem Cell Corporation stock price today is $0.131.
What was International Stem Cell Corporation stock price yesterday?
International Stem Cell Corporation stock price yesterday was $0.144.
What is the PE ratio of International Stem Cell Corporation?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. International Stem Cell Corporation’s P/E ratio is -3.80.
What is the Price-to-Book ratio of International Stem Cell Corporation?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. International Stem Cell Corporation P/B ratio is -0.2955.
What is the 50-day moving average of International Stem Cell Corporation?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. International Stem Cell Corporation 50-day moving average is $0.1405.
How many employess does International Stem Cell Corporation has?
International Stem Cell Corporation has 32 employees.